礼来替尔泊肽注射液多剂量预装笔在中国上市

Core Insights - Eli Lilly announced the launch of the multi-dose prefilled pen for Tirzepatide in China, following the successful introduction of Tirzepatide earlier this year [1] - The new injection device aims to increase supply in China and meet the demand of more patients [1] - Each pen contains four fixed doses, with one dose used per week [1]